Publications by authors named "Emilie Elliot"

Claim this Profile
E
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
Emilie R Elliot, Joseph W Polli, Parul Patel, Louise Garside, Richard Grove

J Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
Paula Teichner, Nadine Chamay, Emilie Elliot, Miguel Pascual-Bernáldez, Deanna Merrill

Open Forum Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
Parul Patel, Paula Teichner, Emilie Elliot, Marta Boffito, Milena Murray

Ther Adv Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics.
Emilie R Elliot, Megan Neary, Laura Else, Saye Khoo, Graeme Moyle

J Antimicrob Chemother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat.
Emilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, Saye Khoo, Nneka Nwokolo

HIV Res Clin Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
Emilie R Elliot, Maddalena Cerrone, Elizabeth Challenger, Laura Else, Alieu Amara

J Antimicrob Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.
Emilie R Elliot, Xinzhu Wang, Suveer Singh, Bryony Simmons, Jaime H Vera

Clin Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
Emilie R Elliot, Maddalena Cerrone, Elizabeth Challenger, Laura Else, Alieu Amara

J Antimicrob Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
Emilie R Elliot, Alieu Amara, Nicole Pagani, Laura Else, Graeme Moyle

J Antimicrob Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
Emilie R Elliot, Alieu Amara, Nicole Pagani, Laura Else, Graeme Moyle

J Antimicrob Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How recent findings on the pharmacokinetics and pharmacodynamics of integrase inhibitors can inform clinical use.
Emilie Elliot, Mimie Chirwa, Marta Boffito

Curr Opin Infect Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.
Emilie R Elliot, Aikaterini Theodoraki, Lakshmi R Jain, Neal J Marshall, Marta Boffito

Clin Med (Lond)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma.
Sujan Dilly Penchala, Sandra Fawcett, Laura Else, Deirdre Egan, Alieu Amara, Emilie Elliot

J Chromatogr B Analyt Technol Biomed Life Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake.
Emilie Elliot, Alieu Amara, Akil Jackson, Graeme Moyle, Laura Else

J Antimicrob Chemother· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis